Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non‐Hodgkin's Lymphoma

INTRODUCTION. To reduce health care costs and improve care, payers and physician groups are switching to quality‐based and episodic or bundled‐care models. Disease progression and associated costs may affect these models, particularly if such programs do not account for differences in disease severi...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Oncologist
Κύριοι συγγραφείς: Reyes, Carolina, Engel‐Nitz, Nicole M., DaCosta Byfield, Stacey, Ravelo, Arliene, Ogale, Sarika, Bancroft, Tim, Anderson, Amy, Chen, May, Matasar, Matthew
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley & Sons, Inc. 2019
Θέματα:
Health Outcomes and Economics of Cancer Care
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738303/
https://ncbi.nlm.nih.gov/pubmed/30808814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0019
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια